Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection
- PMID: 27114329
- DOI: 10.1016/j.fertnstert.2016.04.006
Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection
Abstract
Objective: To investigate flexibility in starting controlled ovarian stimulation at any phase of the menstrual cycle in infertile women undergoing treatment with assisted reproduction.
Design: Retrospective cohort study.
Setting: Academic tertiary-care medical center.
Patient(s): At total of 150 infertile patients undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment. Ninety of the women also underwent frozen embryo transfer (FET) procedures.
Intervention(s): Depending on the phase of the menstrual cycle when ovarian stimulation was started, three groups of patients were identified, namely: conventional group (ovarian stimulation started in the early follicular phase), late follicular phase group, and luteal phase group. When dominant follicles were observed, final oocyte maturation was triggered with the use of GnRH agonist and hCG. In all three groups, viable embryos were cryopreserved for subsequent transfer.
Primary outcome: number of mature oocytes retrieved.
Secondary outcomes: fertilization rate, viable embryo rate per oocyte retrieved, cancellation rate, and clinical pregnancy outcomes from FET cycles.
Results(s): There were no differences in the mean number of mature oocytes retrieved in the conventional group, late follicular phase group, and luteal phase group (5.7 ± 3.6, 5.2 ± 3.7, and 5.2 ± 3.9, respectively). Similarly, no significant differences were observed in the viable embryo rate per oocyte retrieved (37.9%, 38.5%, and 43.6%), clinical pregnancy rates (41.5%, 45.5%, and 38.9%), and implantation rates (30.7%, 30.2%, and 27.1%) in the three groups.
Conclusion(s): All three ovarian stimulation protocols were observed to be equally effective. These results demonstrate that ovarian stimulation can be commenced on any day of the menstrual cycle.
Clinical trial registration number: ChiCTR-OPN-15007332.
Keywords: controlled ovarian stimulation; flexible start for ovarian stimulation; frozen embryo transfer.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.Fertil Steril. 2016 Nov;106(6):1356-1362. doi: 10.1016/j.fertnstert.2016.07.1068. Epub 2016 Aug 1. Fertil Steril. 2016. PMID: 27490046
-
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg.Fertil Steril. 2017 Feb;107(2):379-386.e4. doi: 10.1016/j.fertnstert.2016.10.030. Epub 2016 Nov 16. Fertil Steril. 2017. PMID: 27865446 Clinical Trial.
-
Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.Fertil Steril. 2013 Nov;100(5):1296-302. doi: 10.1016/j.fertnstert.2013.07.1976. Epub 2013 Aug 28. Fertil Steril. 2013. PMID: 23993928
-
Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis.Gynecol Endocrinol. 2014 Jun;30(6):431-7. doi: 10.3109/09513590.2014.895984. Epub 2014 Apr 14. Gynecol Endocrinol. 2014. PMID: 24731070
-
Flexible ovarian stimulation in a poor responder: a case report and literature review.Reprod Biomed Online. 2013 Apr;26(4):378-83. doi: 10.1016/j.rbmo.2012.11.020. Epub 2012 Dec 8. Reprod Biomed Online. 2013. PMID: 23497915 Review.
Cited by
-
Is controlled ovarian stimulation safe in patients with hormone receptor-positive breast cancer receiving neoadjuvant chemotherapy?ESMO Open. 2024 Feb;9(2):102228. doi: 10.1016/j.esmoop.2023.102228. Epub 2024 Jan 16. ESMO Open. 2024. PMID: 38232611 Free PMC article. Review.
-
Luteal Phase Ovarian Stimulation May Improve Oocyte Retrieval and Oocyte Quality in Poor Ovarian Responders Undergoing In Vitro Fertilization: Preliminary Results from a Single-Center Prospective Pilot Study.Adv Ther. 2018 Jun;35(6):847-856. doi: 10.1007/s12325-018-0713-1. Epub 2018 Jun 4. Adv Ther. 2018. PMID: 29869107
-
The cumulative live birth rates of 18 593 women with progestin-primed ovarian stimulation-related protocols and frozen-thawed transfer cycles.Hum Reprod Open. 2023 Dec 21;2024(1):hoad051. doi: 10.1093/hropen/hoad051. eCollection 2024. Hum Reprod Open. 2023. PMID: 38188854 Free PMC article.
-
ART outcomes following ovarian stimulation in the luteal phase:a systematic review and meta-analysis.J Assist Reprod Genet. 2021 Aug;38(8):1927-1938. doi: 10.1007/s10815-021-02237-7. Epub 2021 May 25. J Assist Reprod Genet. 2021. PMID: 34036454 Free PMC article.
-
Effect of Frozen Embryo Transfer and Progestin-primed Ovary Stimulation on IVF outcomes in women with high body mass index.Sci Rep. 2017 Aug 7;7(1):7447. doi: 10.1038/s41598-017-07773-w. Sci Rep. 2017. PMID: 28785018 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials